HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Shigeto Tohma Selected Research

Shigeto Tohma Research Topics

Disease

34	Rheumatoid Arthritis 01/2016 - 08/2003
6	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2015 - 01/2012
6	Infection 01/2015 - 01/2009
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2014 - 01/2010
4	Autoimmune Diseases (Autoimmune Disease) 07/2015 - 01/2013
3	Hypersensitivity (Allergy) 11/2015 - 01/2013
2	Lymphoma (Lymphomas) 04/2015 - 07/2007
2	Pneumonia (Pneumonitis) 01/2015 - 01/2013
2	Dermatomyositis (Dermatopolymyositis) 01/2015 - 01/2012
2	Systemic Scleroderma (Systemic Sclerosis) 01/2015 - 06/2007
2	Vascular Diseases (Vascular Disease) 01/2015 - 01/2015
2	Collagen Diseases (Collagen Disease) 01/2015 - 01/2013
2	Rheumatic Diseases (Rheumatism) 12/2006 - 07/2006
1	Arthritis (Polyarthritis) 11/2015
1	Shock 01/2015
1	Acute Disease 01/2014
1	Proteinuria 01/2014
1	Drug Hypersensitivity (Drug Allergy) 01/2014
1	Vertigo (Positional Vertigo) 01/2013
1	Vomiting 01/2013
1	Stomach Neoplasms (Stomach Cancer) 01/2012
1	Cellulitis 12/2011
1	Sepsis (Septicemia) 12/2011
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2011
1	Sudden Death 09/2011
1	Neoplasms (Cancer) 07/2007
1	Tuberculosis (Tuberculoses) 12/2006
1	Opportunistic Infections (Opportunistic Infection) 12/2006
1	Ulcer 10/2006
1	Relapsing Polychondritis 01/2006
1	Vasculitis (Vasculitides) 12/2004

Drug/Important Bio-Agent (IBA)

6	tocilizumab FDA Link 01/2015 - 01/2009
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012 - 12/2006
5	Methotrexate (Mexate)FDA LinkGeneric 11/2015 - 07/2007
4	Antirheumatic Agents (DMARD)IBA 12/2015 - 07/2011
4	AntibodiesIBA 03/2015 - 12/2006
4	C-Reactive ProteinIBA 01/2012 - 10/2006
3	AntigensIBA 11/2015 - 01/2012
3	abatacept (BELATACEPT)FDA Link 04/2015 - 07/2013
3	HLA-DRB1 antigen (HLA DRB1)IBA 01/2014 - 01/2013
2	GlucocorticoidsIBA 07/2015 - 01/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2015 - 11/2014
2	Tacrolimus (Prograf)FDA LinkGeneric 04/2015 - 01/2015
2	CollagenIBA 01/2015 - 01/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2014 - 02/2013
2	AutoantibodiesIBA 01/2013 - 08/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2013 - 12/2011
2	Biological Markers (Surrogate Marker)IBA 01/2013 - 12/2004
2	PeptidesIBA 06/2007 - 08/2003
2	cyclic citrullinated peptideIBA 12/2006 - 07/2006
2	Rheumatoid FactorIBA 12/2006 - 10/2006
2	AutoantigensIBA 01/2006 - 08/2003
1	OsteopontinIBA 03/2015
1	acetyl 4-aminosalicylic acidIBA 03/2015
1	micaIBA 01/2015
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2015
1	SaltsIBA 01/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2014
1	Interferon Regulatory Factor-2 (Interferon Regulatory Factor 2)IBA 01/2014
1	bucillamine (SA 96)IBA 01/2014
1	GoldIBA 01/2014
1	Penicillamine (Cuprimine)FDA Link 01/2014
1	HLA-DR6 Antigen (HLA DR6 Antigen)IBA 01/2014
1	Carbon MonoxideIBA 01/2013
1	RibonucleoproteinsIBA 01/2013
1	SS-B antibodiesIBA 01/2013
1	HLA-A Antigens (HLA-A)IBA 01/2013
1	HLA-DPB1 (HLA DPB1)IBA 01/2013
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2013
1	TNFR-Fc fusion protein (etanercept)FDA Link 11/2012
1	infliximab (Remicade)FDA Link 11/2012
1	secondary SyphilisIBA 02/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2012
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012
1	Amyopathic dermatomyositisIBA 01/2012
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2012
1	Idiopathic pulmonary hypertensionIBA 09/2011
1	anticentromere antibodyIBA 09/2011
1	3' Untranslated Regions (3' UTR)IBA 01/2011
1	complement C3f-des-arginineIBA 06/2007
1	Immunoglobulin G (IgG)IBA 12/2006
1	agalactosyl IGGIBA 12/2006
1	Tyrosine (L-Tyrosine)FDA Link 12/2004
1	cysteinyl-leukotrieneIBA 12/2004
1	glucuronyl glucosamine glycan sulfate (Vessel)IBA 12/2004
1	EnzymesIBA 08/2003
1	protein-arginine deiminaseIBA 08/2003

Therapy/Procedure

2	Arthroplasty 01/2016 - 01/2009
1	Individualized Medicine 11/2015
1	Retreatment 01/2014
1	Biological Therapy 11/2012
1	Gastrectomy 01/2012